Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoechst Marion Roussel
- Target Recruit Count
- 144
- Registration Number
- NCT00002357
- Locations
- 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸Stanford Univ School of Medicine, Stanford, California, United States
🇺🇸Georgetown Univ Med Ctr, Washington, District of Columbia, United States
A Study of MDL 28,574A in HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoechst Marion Roussel
- Registration Number
- NCT00002329
- Locations
- 🇺🇸
Saint Francis Mem Hosp, San Francisco, California, United States
A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoechst Marion Roussel
- Target Recruit Count
- 200
- Registration Number
- NCT00002150
- Locations
- 🇺🇸
Clinical Investigations Health Services, Mobile, Alabama, United States
🇺🇸California Clinical Trials Med Group, Beverly Hills, California, United States
🇺🇸Southwest Community Based AIDS Treatment Group - COMBAT, Los Angeles, California, United States
A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoechst Marion Roussel
- Target Recruit Count
- 200
- Registration Number
- NCT00002151
- Locations
- 🇺🇸
Clinical Investigations Health Services, Mobile, Alabama, United States
🇺🇸California Clinical Trials Med Group, Beverly Hills, California, United States
🇺🇸Southwest Community Based AIDS Treatment Group - COMBAT, Los Angeles, California, United States
News
iQure Pharma Appoints Former UCB Chief Medical Officer Iris Loew-Friedrich as Clinical and R&D Advisor
iQure Pharma, a clinical-stage biotech company developing treatments for CNS disorders through glutamate balance restoration, has appointed Prof. Dr. Iris Loew-Friedrich as Clinical and R&D Advisor.